Femasys is a biomedical innovator transforming women’s reproductive healthcare through accessible, minimally invasive technologies designed for the OB/GYN setting. With an experienced leadership team committed to advancing care for women, a multi-asset portfolio protected by more than 200 issued global patents, and commercial-ready in-house manufacturing capabilities, Femasys seeks to elevate standards across the reproductive journey.
“From the beginning, my mission has been to transform women’s healthcare by creating true solutions in areas long overlooked by innovation. As a woman and the lead inventor behind our technologies, I have been intentional in designing solutions around women’s needs, prioritizing safety, effectiveness, and minimally invasive products that physicians can easily deliver, while reducing costs and expanding access.”
Kathy Lee-Sepsick, Founder & CEO
“Every innovation at Femasys is designed with the goal of bringing best-in-class care to women worldwide.”
Despite the challenges that have historically limited innovation in women’s health, including chronic underfunding and complex regulatory hurdles, we remain committed to staying the course as we fulfill our mission to deliver transformative solutions that expand options and improve care for women around the world.
